Difference between revisions of "Team:Queens Canada/Circ AFP"
Line 47: | Line 47: | ||
</div> | </div> | ||
− | <div class="intro" style="padding: | + | <div class="intro" style="padding: 60px 200px 20px 200px;"> |
<h1>ICEFINITY: CIRCULARIZED AFP</h1> | <h1>ICEFINITY: CIRCULARIZED AFP</h1> | ||
Line 79: | Line 79: | ||
<figure style="width:600px; display: block; margin-left: auto; margin-right: auto;"> | <figure style="width:600px; display: block; margin-left: auto; margin-right: auto;"> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/8/80/Qqq_QGM_circAFPexpression.png" style="width:600px; display: block; margin-left: auto; margin-right: auto;"> |
<figcaption style="margin-left: 30px;">Figure 3. <strong>SDS-PAGE of unpurified cell lysate components for both wild-type (WT) and circular AFP: supernatant (sup), pellet, and total cell lysate (TCL). </strong>First three columns show the WT AFP, and last three columns show the circAFP. Although the circAFP contains several additional amino acids, it appears to have run further down the gel. Similar results were visualized by the Heidelberg iGEM team in 2014. Cyclized proteins run further than their linear counterparts because of their more compact shape; this allows for the protein to travel through the gel much faster. </figcaption> | <figcaption style="margin-left: 30px;">Figure 3. <strong>SDS-PAGE of unpurified cell lysate components for both wild-type (WT) and circular AFP: supernatant (sup), pellet, and total cell lysate (TCL). </strong>First three columns show the WT AFP, and last three columns show the circAFP. Although the circAFP contains several additional amino acids, it appears to have run further down the gel. Similar results were visualized by the Heidelberg iGEM team in 2014. Cyclized proteins run further than their linear counterparts because of their more compact shape; this allows for the protein to travel through the gel much faster. </figcaption> | ||
Line 87: | Line 87: | ||
<figure style="width: 400px; float: left; margin-top: 50px;"> | <figure style="width: 400px; float: left; margin-top: 50px;"> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/a/a5/Qqq_QGEM_sizeexclusion.png" style="width: 400px;" /> |
<figcaption>Figure 4. <strong>SDS-PAGE of the size exclusion column fractions, depicting the purified circAFP (Fraction A9).</strong> </figcaption> | <figcaption>Figure 4. <strong>SDS-PAGE of the size exclusion column fractions, depicting the purified circAFP (Fraction A9).</strong> </figcaption> | ||
</figure> | </figure> | ||
<figure style="width: 350px; float: right; "> | <figure style="width: 350px; float: right; "> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2015/2/23/Qqq_QGEM_AFPIAP.png" style="width: 260px;"/> |
<figcaption>Figure 5. <strong>SDS-PAGE of ice-affinity purified circAFP</strong>. This gel illustrate the results of one round of IAP. The single band in the last lane indicates the purified circAFP, isolated in the ice fraction. The liquid fraction represents all compounds not incorporated into the ice. </figcaption> | <figcaption>Figure 5. <strong>SDS-PAGE of ice-affinity purified circAFP</strong>. This gel illustrate the results of one round of IAP. The single band in the last lane indicates the purified circAFP, isolated in the ice fraction. The liquid fraction represents all compounds not incorporated into the ice. </figcaption> | ||
</figure> | </figure> |
Revision as of 21:33, 17 September 2015